Program
- Program 2023
Accreditation 2023
- Accreditation 2023
- COI Information
Exhibitors and Sponsors
- ADC 2023 Exhibitors
Program Organizers
Posters

Menu

Program
- Program 2023
Accreditation 2023
- Accreditation 2023
- COI Information
Exhibitors and Sponsors
- ADC 2023 Exhibitors
Program Organizers
Posters

Fatal COVID19 in PD patient on IL-23 inhibitor

Annual Dialysis Conference > Posters > AdultP > Fatal COVID19 in PD patient on IL-23 inhibitor

AdultP

January 28, 2021January 12, 2022 By mimhav

[rumbletalk-chat hash=”L!W:JCCf”]

(1) Methodist Dallas Medical Center (2) American Renal Associates (3) Dallas Nephrology Associates 1037 2021 Adult Dallas Desoto TX

Previous

The Prevalence of Left Ventricular Hypertrophy in Pediatric Patients on Maintenance Dialysis: A Report of the NAPRTCS Registry

The Prevalence of Left Ventricular Hypertrophy in Pediatric Patients on Maintenance Dialysis: A Report of the NAPRTCS Registry

Next

IDENTIFICATION OF MUSCLE WAISTING (SARCOPENIA) BY BIOELECTRICAL IMPEDANCE ANALYSIS IN PATIENTS UNDERGOING CHRONIC RENAL REPLACEMENT THERAPY

IDENTIFICATION OF MUSCLE WAISTING (SARCOPENIA) BY BIOELECTRICAL IMPEDANCE ANALYSIS IN PATIENTS UNDERGOING CHRONIC RENAL REPLACEMENT THERAPY

Presented in cooperation with

Contact

314-516-8419
Conferences@mimh.edu

Program
- Program 2023
Accreditation 2023
- Accreditation 2023
- COI Information
Exhibitors and Sponsors
- ADC 2023 Exhibitors
Program Organizers
Posters